News for Healthier Living

Space-Flown Stem-Cell Organoids May Expose Hidden Drivers of Rare Childhood Diseases

A new review examines how human induced pluripotent stem cells (hiPSCs) and 3D organoids cultured in space could help researchers understand rare and severe pediatric disorders, particularly mitochondrial diseases and congenital heart disorders (CHDs). The authors synthesize evidence that spaceflight conditions alter mitochondrial function, cytoskeletal organization, oxidative stress, calcium handling, cellular maturation, and gene expression, and argue that these responses may converge with disease-associated phenotypes. They also identify key gaps, including the absence of space-based patient-derived models for mitochondrial diseases or CHDs, and propose a framework in which space serves as a discovery environment while validation and therapeutic development remain on Earth. These models preserve patient-specific genetic backgrounds, and the review focuses on pediatric disorders with well-defined genetic causes.

November 3, 2026


November 3 2026

November 2 2026

November 1 2026

October 30 2026

October 29 2026

October 28 2026

October 27 2026

October 26 2026

October 25 2026

October 24 2026

October 23 2026

October 22 2026

October 21 2026

October 20 2026